BioClot А

BioClot А lyophilisate for solution for injection

Packaging Composition Age
250 IU of the drug and 5 mL of the solvent in vials. 500 IU or 1,000 IU of the drug and 10 mL of the solvent in vials Von Willebrand factor and coagulation factor VIII in combination; 1 vial of 250 IU activity contains*: human Von Willebrand factor 250 IU; and human coagulation factor VIII 125 IU 1 vial of 500 IU activity contains*: human Von Willebrand factor 500 IU; and human coagulation factor VIII 250 IU 1 vial of 1,000 IU activity contains*: human Von Willebrand factor 1,000 IU; and human coagulation factor VIII 500 IU For adults only. The drug is not administered to children.
Instructions

Indications:

  • treatment and prophylaxis of bleedings caused by congenital or acquired factor VIII deficiency (haemophilia A, haemophilia A with inhibitors, acquired factor VIII deficiency due to spontaneous development of factor VIII inhibitor)
  • Von Willebrand disease with factor VIII deficiency

publications:

  • Авер'янов Є.В.та ін.:Нові можливості лікування хворих на гемофілію А в умовах клінічного стаціонару Next
Back to the list
X
SELF-MEDICATION CAN BE HARMFUL TO YOUR HEALTH. BEFORE USING THE DRUG, READ THE INSTRUCTION AND CONSULT YOUR PHYSICIAN